CTLA4 - HEK293 Recombinant Cell Line

Products from BPS Bioscience require a minimum order value above 400€

Applications: Screening for CTLA4 binding molecules (such as anti-CTLA4 antibody) in a cellular context

Background: CTLA4 is a member of the immunoglobulin superfamily. It is expressed by activated T cells and transmits an inhibitory signal to T cells. CTLA4 is homologous to the T-cell co-stimulatory protein, CD28, and both molecules bind to CD80 (B7-1) and CD86 (B7-2) on antigen-presenting cells. CTLA-4 binds CD80 and CD86 with greater affinity and avidity than CD28 thus enabling it to outcompete CD28 for its ligands and act as an "off" switch when bound to CD80 or CD86. Not surprisingly, CTLA-4 is an important drug target for the regulation of the host's response to cancer.

Description: Recombinant HEK293 stably expressing human CTLA4 (Cytotoxic T-Lymphocyte Associated Protein; CD152), GenBank Accession #NM_005214.

Host Cell Line: HEK293

Mycoplasma Testing: The cell line has been screened using the metabolite-based Mycoplasma Detection Kit (Biotool, #B3903) to confirm the absence of Mycoplasma species.

Storage Stability: Immediately upon receipt, store in liquid nitrogen.

Supplied As: Each vial contains ~3 X 10^6 cells in 1 ml of 10% DMSO.

Warnings: Avoid freeze/thaw cycles.

Biosafety Level: BSL-2

• Artikelnummer: BPS60681
• Hersteller: BPS Bioscience
• Hersteller Artikelnummer: 60681
• Verpackungseinheit: 2 vials
• Mengeneinheit: PAK
• Wirt: Human